Evommune, Inc.
Ticker: 2044725
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY25 | Q1 FY25 |
|---|---|---|
| INCOME | ||
| Revenue | 10.00+233.3% | 3.00 |
| Total Income | 10.00+233.3% | 3.00 |
| EXPENSES | ||
| Expenditure | 23.33+29.4% | 18.03 |
| Tax | 0.00 | 0.00 |
| PROFIT | ||
| Net Profit | -12.48+14.3% | -14.56 |
| KEY METRICS | ||
| OPM % | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% |
| EPS | -8.07+14.9% | -9.48 |
Corporate Events
Board MeetingEVMN
20262Jun
Board Meeting
2026 Annual Meeting of Stockholders held to elect directors …
SEC Filing ↗